A Single-Centre Open-label Pharmacology Study of Topically Applied MTC896 Gel in Healthy Volunteers.
Completed
- Conditions
- Acne
- Registration Number
- ACTRN12617000498392
- Lead Sponsor
- Mimetica Pty Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does MTC896 gel target in acne treatment?
How does MTC896 gel compare to standard-of-care acne treatments in clinical efficacy?
Are there specific biomarkers that predict response to MTC896 gel in acne patients?
What are the known or potential adverse events associated with MTC896 gel application?
What related compounds or competitor drugs are being developed for acne treatment by Mimetica Pty Ltd?